Basic Study
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Aug 15, 2025; 17(8): 106781
Published online Aug 15, 2025. doi: 10.4251/wjgo.v17.i8.106781
Figure 7
Figure 7 GEN1 knockdown sensitizes gastric cancer cells to ferroptosis and cisplatin. A: Ferrostatin-1 rescues cell viability in GEN1-knockdown AGS cells. Data are mean ± SD (n = 3); B: Dose-response curves of cisplatin in negative control with scrambled shRNA and shGEN1 AGS cells. Half-maximal inhibitory concentration values: ShCtrl = 5.9 μM, shGEN1 = 2.8 μM (P < 0.001, unpaired t-test). bP < 0.01. cP < 0.001. 1P vs negative control with scrambled shRNA. 2P vs shGEN1 (two-way analysis of variance). shCtrl: Negative control with scrambled shRNA; sh: Short hairpin; IC50: Half-maximal inhibitory concentration.